CSF3 and non-small cell lung carcinoma: In patients with locally advanced NSCLC treated with predominantly conventionally or slightly hypofractionated radiation therapy, this study demonstrated a significant correlation of the pre-treatment cytokine biomarkers CCL4 and G-CSF with RILF2 risk.